CompaniesByCap
VRDN
Viridian Therapeutics Inc. (VRDN)
NASDAQ · Healthcare

Viridian Therapeutics Inc. Cash Flow 2013–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013
Operating Activities
Operating Cash Flow-276.4M-232.3M-184.2M-93.8M-54.6M-29.8M-36.1M-26.8M-28.2M-14.8M-6.9M-2.2M-1.2M
Depreciation & Amort.
Investing Activities
Capital Expenditure495,000511,000898,000797,000338,00042,00084,000445,000246,000250,000123,000266,0005,000
Free Cash Flow-276.9M-232.8M-185.1M-94.6M-54.9M-29.8M-36.1M-27.3M-28.4M-15.0M-7.0M-2.5M-1.2M
Financing Activities
Dividends Paid
Stock Buybacks2,000

Viridian Therapeutics Inc. Cash Flow — FAQ

Viridian Therapeutics Inc. (VRDN) cash flow over the last 13 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see VRDN's cash flow history?

The chart and table above show Viridian Therapeutics Inc.'s cash flow by year and by quarter, including the growth rate.